BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3262687)

  • 1. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes and complement components in Bell's palsy.
    Jonsson L; Larsson A; Thomander L
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(6):294-301. PubMed ID: 3501560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of circulating immune complexes by chicken anti-C4 micro ELISA.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1988 Sep; 27(1):39-43. PubMed ID: 3150766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bell's palsy: an immune complex disease.
    Larsson A; Jonsson L; Sjöquist J
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(3):164-7. PubMed ID: 2141682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent.
    Samuel DJ; Amlot PL; Shepherd P; Lachmann PJ
    Clin Exp Immunol; 1986 Aug; 65(2):458-64. PubMed ID: 3491710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
    Smith AJ; Kyle V; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1987 Jun; 46(6):468-74. PubMed ID: 2820320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.
    Melsom RD; Horsfall AC; Schrieber L; Charles P; Maini RN
    Rheumatol Int; 1986; 6(5):227-31. PubMed ID: 3492027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
    Stanilova SA; Slavov ES
    J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.
    Wager O; Lindstrøm P
    Scand J Immunol; 1982 Mar; 15(3):319-28. PubMed ID: 6979777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.